158 related articles for article (PubMed ID: 12890817)
1. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A.
Vainzof M; de Paula F; Tsanaclis AM; Zatz M
J Clin Pathol; 2003 Aug; 56(8):624-6. PubMed ID: 12890817
[TBL] [Abstract][Full Text] [Related]
2. [A case of LGMD2A identified with both western blot analysis and immunostaining of calpain 3 in biopsied muscle].
Ibi T; Jing L; Nakao N; Minami N; Sahashi K
Rinsho Shinkeigaku; 2000 Oct; 40(10):1023-7. PubMed ID: 11296367
[TBL] [Abstract][Full Text] [Related]
3. Molecular diagnosis in LGMD2A: mutation analysis or protein testing?
Fanin M; Fulizio L; Nascimbeni AC; Spinazzi M; Piluso G; Ventriglia VM; Ruzza G; Siciliano G; Trevisan CP; Politano L; Nigro V; Angelini C
Hum Mutat; 2004 Jul; 24(1):52-62. PubMed ID: 15221789
[TBL] [Abstract][Full Text] [Related]
4. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle.
Keira Y; Noguchi S; Minami N; Hayashi YK; Nishino I
J Biochem; 2003 May; 133(5):659-64. PubMed ID: 12801918
[TBL] [Abstract][Full Text] [Related]
5. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures.
Mercuri E; Bushby K; Ricci E; Birchall D; Pane M; Kinali M; Allsop J; Nigro V; Sáenz A; Nascimbeni A; Fulizio L; Angelini C; Muntoni F
Neuromuscul Disord; 2005 Feb; 15(2):164-71. PubMed ID: 15694138
[TBL] [Abstract][Full Text] [Related]
7. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
8. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression.
Fanin M; Nascimbeni AC; Fulizio L; Trevisan CP; Meznaric-Petrusa M; Angelini C
Am J Pathol; 2003 Nov; 163(5):1929-36. PubMed ID: 14578192
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.
Baghdiguian S; Richard I; Martin M; Coopman P; Beckmann JS; Mangeat P; Lefranc G
J Mol Med (Berl); 2001 Jun; 79(5-6):254-61. PubMed ID: 11485017
[TBL] [Abstract][Full Text] [Related]
10. Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.
Hauerslev S; Sveen ML; Duno M; Angelini C; Vissing J; Krag TO
BMC Musculoskelet Disord; 2012 Mar; 13():43. PubMed ID: 22443334
[TBL] [Abstract][Full Text] [Related]
11. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls.
Fanin M; Angelini C
Muscle Nerve; 2015 Aug; 52(2):163-73. PubMed ID: 25900067
[TBL] [Abstract][Full Text] [Related]
12. Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A).
Spencer MJ; Tidball JG; Anderson LV; Bushby KM; Harris JB; Passos-Bueno MR; Somer H; Vainzof M; Zatz M
J Neurol Sci; 1997 Mar; 146(2):173-8. PubMed ID: 9077514
[TBL] [Abstract][Full Text] [Related]
13. Clinical variability in calpainopathy: what makes the difference?
de Paula F; Vainzof M; Passos-Bueno MR; de Cássia M Pavanello R; Matioli SR; V B Anderson L; Nigro V; Zatz M
Eur J Hum Genet; 2002 Dec; 10(12):825-32. PubMed ID: 12461690
[TBL] [Abstract][Full Text] [Related]
14. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy.
Chae J; Minami N; Jin Y; Nakagawa M; Murayama K; Igarashi F; Nonaka I
Neuromuscul Disord; 2001 Sep; 11(6-7):547-55. PubMed ID: 11525884
[TBL] [Abstract][Full Text] [Related]
15. Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice.
Richard I; Roudaut C; Marchand S; Baghdiguian S; Herasse M; Stockholm D; Ono Y; Suel L; Bourg N; Sorimachi H; Lefranc G; Fardeau M; Sébille A; Beckmann JS
J Cell Biol; 2000 Dec; 151(7):1583-90. PubMed ID: 11134085
[TBL] [Abstract][Full Text] [Related]
16. Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.
Toral-Ojeda I; Aldanondo G; Lasa-Elgarresta J; Lasa-Fernández H; Fernández-Torrón R; López de Munain A; Vallejo-Illarramendi A
Expert Rev Mol Med; 2016 Apr; 18():e7. PubMed ID: 27055500
[TBL] [Abstract][Full Text] [Related]
17. Novel Missense CAPN3 Mutation Responsible for Adult-Onset Limb Girdle Muscular Dystrophy with Calves Hypertrophy.
Rekik S; Sakka S; Ben Romdhan S; Farhat N; Baba Amer Y; Lehkim L; Authier FJ; Mhiri C
J Mol Neurosci; 2019 Dec; 69(4):563-569. PubMed ID: 31410652
[TBL] [Abstract][Full Text] [Related]
18. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
[TBL] [Abstract][Full Text] [Related]
19. Early onset calpainopathy with normal non-functional calpain 3 level.
Lanzillo R; Aurino S; Fanin M; Aguennoz M; Vitale F; Fiorillo C; Del Giudice E; Nigro V; Santoro L
Dev Med Child Neurol; 2006 Apr; 48(4):304-6. PubMed ID: 16542520
[TBL] [Abstract][Full Text] [Related]
20. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain.
Jia Z; Petrounevitch V; Wong A; Moldoveanu T; Davies PL; Elce JS; Beckmann JS
Biophys J; 2001 Jun; 80(6):2590-6. PubMed ID: 11371436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
